Logo of BTC Health (ASX:BTC)Latest BTC Health (ASX:BTC) News

Page 1
Page 1 of 2

Healthcare Wrap - Week 45 (2 Nov -> 6 Nov) 2026

Healthcare shares delivered a mixed week as investors rewarded reimbursement and regulatory progress but punished cash calls and dilution. Noxopharm, Pacific Edge and Mayne Pharma led the largest moves, while several companies still face long waits before sales can grow.
Logan Eniac
7 Nov 2026

BTC Health Adds India to Exclusive PEARS Distribution Agreement

BTC Health has expanded its exclusive ExoVasc PEARS distribution rights from Australia into India under a new five-year agreement. The opportunity is potentially significant, but Indian sales remain dependent on CDSCO import approval.
Ada Torres
6 Nov 2026

Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026

Two capital raisings and one brutal reset set the tone, even as several companies posted clean growth or strong clinical updates. Radiopharmaceuticals kept delivering good news, but investors still punished supply-chain and cash needs fast.
Logan Eniac
21 Feb 2026

BTC Health Navigates Delays as Cardio Revenue Surges to 53%

BTC Health reports a slight statutory loss in HY26 amid a 7% revenue dip, offset by strong growth in its cardio segment driven by key hospital contracts.
Ada Torres
19 Feb 2026

Healthcare Wrap - Week 7 (9 Feb -> 13 Feb) 2026

Healthcare stocks split into two stories this week: big names sold off hard, while a few small caps ran on clear news. The biggest moves came from a sharp fall in Pro Medicus and Cochlear, while Noxopharm jumped after a top-tier journal publication.
Logan Eniac
14 Feb 2026

BTC Health Secures Exclusive Australian Rights for Jafron Hemoperfusion Cartridges

BTC Health’s investee, BTC Cardio, has landed exclusive Australian distribution rights for Jafron Biomedical’s hemoperfusion cartridges, aiming for a 2026 market debut pending regulatory approval.
Ada Torres
13 Feb 2026

BTC Health Accelerates Growth with $2M Placement and 36% Revenue Surge

BTC Health has reissued its Chairman’s Address with added financial details, highlighting a strategic shift towards diversified medical products and a strong start to FY26 with 36% revenue growth.
Ada Torres
3 Dec 2025

BTC Health Accelerates Diversification with $2M Raise Amid ECMO Growth Hopes

BTC Health has broadened its medical product portfolio through strategic acquisitions and organic growth, reporting strong early revenue gains while cautiously navigating the uncertain timing of ECMO system adoption.
Ada Torres
28 Nov 2025

BTC Health Secures $2M in Share Placement Backed by Director and New Investor

BTC Health has raised $2 million through a share placement priced at a slight premium, with director Martin Kahanovitz participating and a new South African investor joining the register.
Ada Torres
28 Nov 2025

BTC Health Accelerates Growth with $5M ECMO Contract and Diversified Portfolio

BTC Health Limited reported a robust 25% revenue increase in FY25, driven by strategic contract wins and expanded product offerings across critical medical sectors. The company’s positive EBITDA and new partnerships position it well for continued growth in FY26.
Ada Torres
28 Aug 2025

BTC Health Surges to $4m Profit, Lands $5m Hospital Deal

BTC Health reports a strong FY25 with a $4 million statutory profit, boosted by a $5 million contract and strategic acquisition. The company eyes further growth in FY26 with new product launches and expanded market reach.
Ada Torres
28 Aug 2025

BTC Health’s Profit Soars 277% on Strategic Healthcare Investments

BTC Health Limited reported a remarkable 277% increase in profit after tax to nearly $4 million for FY25, driven by significant fair value gains on its healthcare investments and key contract wins.
Ada Torres
28 Aug 2025